The result showed that the proportion of live CD45+, CD45+TCRβ+, CD45+TCRβ+CD4+, and CD45+TCRβ+CD8+ cells were increased in TNFR2-/- tumor tissues (Figure S7). This evidence concerns the gene CD8A and neoplasm.